Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thebaine is a naturally occurring opiate alkaloid found in the opium poppy (Papaver somniferum) and related species. Chemically similar to morphine and codeine, it differs by having stimulatory rather than depressant effects. At high doses, it can cause convulsions similar to strychnine poisoning. Thebaine itself is not used therapeutically but serves as a key precursor for the industrial synthesis of several important opioid medications including hydrocodone, oxycodone, oxymorphone, naloxone, naltrexone, buprenorphine and others. Its mechanism of action includes antagonism at glycine and GABA receptors in addition to weak activity at opioid receptors; however its primary pharmacological significance lies in its role as a chemical intermediate rather than as an active pharmaceutical ingredient[3][4][7][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thebaine.